The short version
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
equate lansoprazole
lansoprazole · LANSOPRAZOLE 15 mg/1 · Tablet, Orally Disintegrating, Delayed Release · Oral · Wal-Mart Stores Inc
NDC 49035-0373-55 · 42 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00378-6981-88) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$4.48per unit
middle half $3.42–$5.05 · 293 plans · Apr 1, 2026
Est. net of rebatesⓘ
$2.69–$3.36
brand drug — est. 25-40% rebate off the price at left
Coverage & restrictions
5%of plans cover it
tier 4 · prior auth 0% · step therapy 92% · qty limit 88%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for lansoprazole (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA208025
- TE code
- —
- Approval date
- Jun 7, 2016
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11077055 | Apr 21, 2036 |
| patent | 11986554 | Apr 21, 2036 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of lansoprazole (Tablet, Orally Disintegrating, Delayed Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amazon.com Services LLC | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cardinal Health 107, LLC | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| NorthStar Rx LLC | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| CVS Pharmacy | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddys Laboratories Inc | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Kroger Company | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| L. Perrigo Company | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Ireland Ltd. | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Ireland Ltd. | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | LANSOPRAZOLE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Wal-Mart Stores Inc | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Company | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx LLC | LANSOPRAZOLE 15 mg/1 | Jul 15, 2026 | Aug 30, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "equate lansoprazole — NDC 49035-0373-55," retrieved September 3, 2026, https://drugdashboards.com/drug/49035037355.
Free to cite with attribution — see how the data is put together.